Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer

Cancer Research

Volumn 56, Issue 8, 1996, Pages 1823-1827

  Buscail, Louis ^a   Saint Laurent, Nathalie ^a   Chastre, Eric ^b   Vaillant, Jean Christophe ^b   Gespach, Christian ^b   Capellà, Gabriel ^c   Kalthoff, Holger ^d   Lluis, Felix ^c   Vaysse, Nicole ^a   Susini, Christiane ^a  

^a CHU RANGUEIL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN RECEPTOR; VAPREOTIDE;

ADENOMATOUS POLYP; ARTICLE; CANCER INVASION; CANCER STAGING; COLORECTAL CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; PANCREAS CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE; COLORECTAL NEOPLASMS; GENE EXPRESSION; HUMANS; INTESTINE, LARGE; NEOPLASM STAGING; PANCREAS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, SOMATOSTATIN; REFERENCE VALUES; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 9244237087     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Lewin, M. J M. The somatostatin receptors in the GI tract Annu. Rev. Physiol , 54: 455-469, 1992
2. Lamberts, S. W J., Krenning, E. P., and Reubi, J C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev., 12: 450-482, 1991.
3. Arnold, R., Benning, R. Neuhaus, R., Rolwage, M., and Trautmann, M. E. Gastroenteropancreatic endocrine tumours: effect of sandostatin on tumour growth. Digestion, 54 (Suppl 1): 72-75, 1993.
4. Schally, A. V. Oncological applications of somatostatin analogues Cancer Res , 48: 6977-6985, 1988
5. Yamada, Y , Post, S. R , Wang, K., Tager, H. S., Bell, G I , and Seino, S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl Acad Sci. USA, 89: 251-255, 1992
6. Yamada, Y., Reisine, T , Law, S., Ihara, Y., Kubota, A , Kagimoto, S., Seino, M., Seino, Y., Bell, G. I , and Seino, S Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol., 6: 2136-2142, 1992.
7. Xu, Y , Song, J., Bruno, J F , and Berelowitz, M Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4. Biochem. Biophys. Res. Commun., 193: 648-652, 1993.
8. Yamada, Y , Kagimoto, S , Kubota A , Yasuda, K., Masuda, K., Someya, Y., Ihara, Y , Li, Q., Imura, H , Seino, S., and Seino, Y Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and fifth (hSSTR5) human somatostatin receptor subtype. Biochem. Biophys. Res Commun., 195 844-852, 1993
9. Bell, G. I., and Reisine, T. Molecular biology of somatostatin receptors. Trends Neurosci., 16: 34-38, 1993
10. Hoyer, D., Bell, G. I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P. P. A., O'Carroll, A-M , Patel, Y. C., Schonbrunn, A., Taylor, J. E , and Reisine, T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci., 16. 86-88, 1995.
11. Buscail, L., Delesque, N., Estève, J-P., Saint-Laurent, N., Prats, H., Clerc, P , Robberecht, P., Bell, G. I., Liebow, C., Schally, A. V., Vaysse, N., and Susini, C Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues. mediation by human receptor subtypes SSTR1 and SSTR2. Proc. Natl Acad Sci USA, 91: 2315-2319, 1994
12. Buscail, L., Estève, J-P , Saint-Laurent, N , Bertrand, V., Reisine, T., O'Carroll, A-M., Bell, G. I., Schally, A V., Vaysse, N , and Susini, C Inhibition of cell proliferation by the somatostatin analogues RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc. Natl. Acad. Sci. USA, 92: 1580-1584, 1995
13. Raynor, K., Murphy, W A., Coy, D. H , Taylor, J E , Moreau, J-P., Yasuda, K., Bell, G I., and Reisine, T. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity of linear peptides. Mol. Pharmacol , 43: 838-844, 1993.
14. O'Carroll, A-M., Raynor, K , Lolait, S. J., and Reisine, T. Characterization of cloned human somatostatin receptor SSTR5. Mol. Pharmacol., 46: 291-298, 1994
15. Patel, Y. C., and Srikant, C. B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology, 135: 2814-2817, 1994.
16. Greenman, Y , and Memeld, S. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J. Clin. Endocrinol Metab , 78: 398-403, 1994
17. Panetta, R., and Patel, Y C. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci., 56: 333-342, 1995.
18. Kubota, A., Yamada, Y., Kagimoto, S , Shimatsu, A , Imamura, M., Tsuda, K , Imura, H., Seino, S., and Seino, Y Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors J. Clin Invest., 93. 1321-1325, 1994.
19. Reubi, J. C., Schaer, J. C., Waser, B., and Mengod, G Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res., 54: 3455-3459, 1994
20. Viguerie, N., Tahiri-Jouti, N , Ayral, A-M., Cambillau, C., Scemama, J-L., Bastié, M-J., Knuhtsen, S., Estève, J-P., Pradayrol, L., Vaysse, N., and Susini, C. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Endocrinology, 124: 1017-1025, 1989.
21. Schally, A. V. Hypothalamic hormones: from neuroendocrinology to cancer therapy. Anti-Cancer Drugs, 5: 115-130, 1994.
22. Dy, D. Y , Whitehead, R. H., and Morris, D. L. SMS 201-995 inhibits in vitro and in vivo growth of human colon cancer. Cancer Res., 52. 917-923, 1992
23. Friess, H , Buchler, M., Beglinger, C., Weber, A., Kunz, J , Fritsch, K , Dennler, H. J., and Beger, H. G. low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer Pancreas, 8: 540-545, 1993.
24. Klijn, J. G. M., Hoff, A. M., Planting, A. S. Th. Verweij, J , Kok, T., Lamberts, S. W. J., Portengen, H., and Foekens, J. A. Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue sandostatin a phase II study including endocrine effects. Br J Cancer, 62: 627-630, 1990.
25. Smith, J. P , Doll, D , Croitoru, R , Thornton, C , and Perry, M. C. Octreotide has no effect on advanced colon cancer. J. Clin. Gastroenterol., 18. 245-247, 1994.
26. Fekete, M., Zalatnai, A., Comaru-Schally, A-M., and Schally, A. V. Membrane receptors for peptides in experimental and human pancreatic cancers Pancreas, 4: 521-528, 1989.
27. Reubi, J. C., Horisberger, U., Essed, C E , Jeekel, J., Klijn, J. H G., and Lamberts, S. W. J. Absence of somatostatin receptors in human exocrine pancreatic cancer. Gastroenterology, 95: 760-763, 1988.
28. Astler, V B., and Coller, F. A. The prognosis significance of direct extension of carcinoma of the colon and rectum. Ann. Surg., 139: 846-851, 1954.
29. Fu, X., Fiorella, G., and Hoffman, R. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histopathologically intact patient specimens Proc. Natl. Acad Sci USA, 89: 5645-5649, 1992.
30. Reyes, G., Villanueva, A., Pujol, M., Farré, A , Lluis, F , and Capellà, G Orthotopic implantation of human carcinomas of the exocrine pancreas in nude mice Pancreas, 8. 770, 1993.
31. Chomczynski, P., and Sacchi, N Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chlorophorm extraction. Anal Biochem., 162: 156-159, 1987.
32. Dukas, K., Sarfau, P., Vaysse, N , and Pradayrol, L Quantification of changes in the expression of multiple genes by simultaneous polymerase chain reactions Anal. Biochem , 215: 66-72, 1993
33. Vidal, C , Rauly, I., Zeggari, M , Delesque, N., Estève, J-P., Saint-Laurent, N., Vaysse, N., and Susini, C. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells. Mol Pharmacol., 45: 97-104, 1994
34. Nudel, U., Zakut, R , Shani, M., Neuman S , Levy, Z , and Yaffe, D. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res., 11. 1759-1771, 1983.
35. Tahiri-Jouti, N., Cambillau, C., Viguerie, N , Vidal, C., Buscail, L., Saint-Laurent, N., Vaysse, N., and Susini, C. Characterization of a membrane tyrosine phosphatase activity in AR4-2J cells. regulation by somatostatin. Am. J. Physiol. 262. G1007-G1014, 1992.
36. Liebow, C., Reilly, C., Serrano, M., and Schally, A. V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad. Sci. USA, 86. 2003-2007, 1989.
37. Townsend, C. M., Jr , Singh, P. and Thompson, J. C Effects of gastrointestinal peptides on gastrointestinal cancer growth. Gastroenterol Clin. North Am., 18: 777-791, 1989.